Literature DB >> 26903516

Insights into the Effects of Complement Factor H on the Assembly and Decay of the Alternative Pathway C3 Proconvertase and C3 Convertase.

Serena Bettoni1, Elena Bresin1, Giuseppe Remuzzi2, Marina Noris3, Roberta Donadelli1.   

Abstract

The activated fragment of C3 (C3b) and factor B form the C3 proconvertase (C3bB), which is cleaved by factor D to C3 convertase (C3bBb). Older studies (Conrad, D. H., Carlo, J. R., and Ruddy, S. (1978)J. Exp. Med.147, 1792-1805; Pangburn, M. K., and Müller-Eberhard, H. J. (1978)Proc. Natl. Acad. Sci. U.S.A.75, 2416-2420; Kazatchkine, M. D., Fearon, D. T., and Austen, K. F. (1979)J. Immunol.122, 75-81) indicated that the complement alternative pathway regulator factor H (FH) competes with factor B for C3b binding; however, the capability of FH to prevent C3bB assembly has not been formally investigated. Moreover, in the few published studies FH did not favor C3bB dissociation. Whether FH may affect C3bBb formation from C3bB is unknown. We set up user-friendly assays based on combined microplate/Western blotting techniques that specifically detect either C3bB or C3bBb, with the aim of investigating the effect of FH on C3bB assembly and decay and C3bBb formation and decay. We document that FH does not affect C3bB assembly, indicating that FH does not efficiently compete with factor B for C3b binding. We also found that FH does not dissociate C3bB. FH showed a strong C3bBb decay-accelerating activity, as reported previously, and also exerted an apparent inhibitory effect on C3bBb formation. The latter effect was not fully attributable to a rapid FH-mediated dissociation of C3bBb complexes, because blocking decay with properdin and C3 nephritic factor did not restore C3bBb formation. FH almost completely prevented release of the smaller cleavage subunit of FB (Ba), without modifying the amount of C3bB complexes, suggesting that FH inhibits the conversion of C3bB to C3bBb. Thus, the inhibitory effect of FH on C3bBb formation is likely the sum of inhibition of C3bB conversion to C3bBb and of C3bBb decay acceleration. Further studies are required to confirm these findings in physiological cell-based settings.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  C3 convertase; C3 nephritic factor; C3 proconvertase; Western blot; alternative pathway complement system; complement; convertase; factor H; magnesium; manganese

Mesh:

Substances:

Year:  2016        PMID: 26903516      PMCID: PMC4825022          DOI: 10.1074/jbc.M115.693119

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

Review 1.  Complement analysis in the 21st century.

Authors:  Tom Eirik Mollnes; T Sakari Jokiranta; Lennart Truedsson; Bo Nilsson; Santiago Rodriguez de Cordoba; Michael Kirschfink
Journal:  Mol Immunol       Date:  2007-09       Impact factor: 4.407

2.  Immunology. The new view of complement.

Authors:  Mitch Leslie
Journal:  Science       Date:  2012-08-31       Impact factor: 47.728

3.  Structures of complement component C3 provide insights into the function and evolution of immunity.

Authors:  Bert J C Janssen; Eric G Huizinga; Hans C A Raaijmakers; Anja Roos; Mohamed R Daha; Kristina Nilsson-Ekdahl; Bo Nilsson; Piet Gros
Journal:  Nature       Date:  2005-09-22       Impact factor: 49.962

4.  Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and beta1 H for cell-bound C3b.

Authors:  M D Kazatchkine; D T Fearon; K F Austen
Journal:  J Immunol       Date:  1979-01       Impact factor: 5.422

5.  CRIT peptide interacts with factor B and interferes with alternative pathway activation.

Authors:  Kwok-Min Hui; Bergljót Magnadóttir; Jürg A Schifferli; Jameel M Inal
Journal:  Biochem Biophys Res Commun       Date:  2006-03-27       Impact factor: 3.575

6.  C3 convertase of human complement: enhanced formation and stability of the enzyme generated with nickel instead of magnesium.

Authors:  Z Fishelson; H J Müller-Eberhard
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

7.  Coexistence of closed and open conformations of complement factor B in the alternative pathway C3bB(Mg2+) proconvertase.

Authors:  Eva Torreira; Agustín Tortajada; Tamara Montes; Santiago Rodríguez de Córdoba; Oscar Llorca
Journal:  J Immunol       Date:  2009-11-04       Impact factor: 5.422

8.  Eculizumab in a patient with dense-deposit disease.

Authors:  Erica Daina; Marina Noris; Giuseppe Remuzzi
Journal:  N Engl J Med       Date:  2012-03-22       Impact factor: 91.245

Review 9.  Age-related macular degeneration and the role of the complement system.

Authors:  Selina McHarg; Simon J Clark; Anthony J Day; Paul N Bishop
Journal:  Mol Immunol       Date:  2015-03-21       Impact factor: 4.407

10.  Structural basis for engagement by complement factor H of C3b on a self surface.

Authors:  Hugh P Morgan; Christoph Q Schmidt; Mara Guariento; Bärbel S Blaum; Dominic Gillespie; Andrew P Herbert; David Kavanagh; Haydyn D T Mertens; Dmitri I Svergun; Conny M Johansson; Dušan Uhrín; Paul N Barlow; Jonathan P Hannan
Journal:  Nat Struct Mol Biol       Date:  2011-02-13       Impact factor: 15.369

View more
  7 in total

1.  Novel interaction of properdin and coagulation factor XI: Crosstalk between complement and coagulation.

Authors:  Samantha L Heal; Lewis J Hardy; Clare L Wilson; Majid Ali; Robert A S Ariëns; Richard Foster; Helen Philippou
Journal:  Res Pract Thromb Haemost       Date:  2022-05-24

Review 2.  Complement related kidney diseases: Recurrence after transplantation.

Authors:  Maurizio Salvadori; Elisabetta Bertoni
Journal:  World J Transplant       Date:  2016-12-24

Review 3.  Thrombotic microangiopathy after renal transplantation: Current insights in de novo and recurrent disease.

Authors:  Fedaey Abbas; Mohsen El Kossi; Jon Jin Kim; Ajay Sharma; Ahmed Halawa
Journal:  World J Transplant       Date:  2018-09-10

4.  A novel PIK3CD C896T mutation detected in bilateral sudden sensorineural hearing loss using next generation sequencing: An indication of primary immunodeficiency.

Authors:  Jing Zou; Xiangqiang Duan; Guiliang Zheng; Zhen Zhao; Shiyue Chen; Pu Dai; Hongliang Zheng
Journal:  J Otol       Date:  2016-06-08

5.  The importance of sialic acid, pH and ion concentration on the interaction of uromodulin and complement factor H.

Authors:  Lufeng Bai; Qiuyu Xie; Min Xia; Kunjing Gong; Na Wang; Yuqing Chen; Minghui Zhao
Journal:  J Cell Mol Med       Date:  2021-03-31       Impact factor: 5.310

Review 6.  The Immune Response against Acinetobacter baumannii, an Emerging Pathogen in Nosocomial Infections.

Authors:  María Guadalupe García-Patiño; Rodolfo García-Contreras; Paula Licona-Limón
Journal:  Front Immunol       Date:  2017-04-12       Impact factor: 8.786

Review 7.  Viral Evasion of the Complement System and Its Importance for Vaccines and Therapeutics.

Authors:  Jack Mellors; Tom Tipton; Stephanie Longet; Miles Carroll
Journal:  Front Immunol       Date:  2020-07-09       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.